See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $446B | 7.4x | 17.3x | |
| $367B | 4.3x | 15.5x | |
| $229B | 4.5x | 18.7x | |
| $177B | 2.6x | 12.1x | |
| $69.1B | 3.4x | 14.0x | |
| $67.9B | 1.3x | 6.1x | |
| $63.5B | 8.7x | 38.1x | |
| $63.1B | 3.4x | 12.1x | |
| $52.1B | 3.6x | 14.2x | |
| $45.5B | 8.9x | 38.6x | |
| $43.5B | 4.7x | 19.2x | |
| $39.1B | 2.6x | 11.5x | |
| $38.8B | 2.7x | 18.5x | |
| $33.4B | 1.4x | 7.7x | |
| $25.4B | 2.1x | 14.3x | |
| $22.7B | 3.7x | 16.1x | |
| $22.6B | 1.5x | 8.1x | |
| $22.3B | 2.2x | 6.4x | |
| $21.1B | 1.8x | 10.6x | |
| $19.2B | 1.8x | 11.7x | |
| $13.4B | 7.8x | 37.8x | |
| $12.2B | 2.1x | 14.4x | |
| $11.3B | 7.3x | 28.7x | |
| $10.8B | 1.9x | 9.3x | |
| $10.2B | 7.5x | 39.9x | |
| $10.1B | 6.9x | 36.8x | |
| $9.2B | 1.4x | 8.3x | |
| $8.0B | 1.3x | 12.3x | |
| $7.4B | 1.3x | 7.0x | |
| $6.5B | 9.5x | 29.7x | |
| $6.0B | 6.6x | 26.4x | |
| $6.0B | 2.8x | 16.6x | |
| $5.3B | n/a | n/a | |
| $5.3B | 3.6x | 17.4x | |
| $4.9B | 1.7x | 7.4x | |
| $4.8B | 9.5x | 37.7x | |
| $4.7B | 10.7x | 33.7x | |
| $4.7B | 1.6x | 10.9x | |
| $4.2B | 3.6x | 22.6x | |
| $4.1B | 1.3x | 8.0x | |
| $4.0B | n/a | n/a | |
| $3.8B | 3.4x | 10.4x | |
| $3.6B | 1.1x | 6.7x | |
| $3.4B | 2.1x | 11.4x | |
| $3.3B | 1.6x | 9.5x | |
| $3.1B | 9.5x | 36.0x | |
| $2.9B | 1.9x | 9.8x | |
| $2.8B | 2.7x | 12.2x | |
| $2.6B | 0.8x | 5.1x | |
| $2.5B | 1.2x | 9.1x | |
| $2.5B | 5.6x | 20.8x | |
| $2.5B | 0.5x | 6.4x | |
| $2.5B | 0.5x | 4.3x | |
| $2.4B | 3.0x | 14.8x | |
| $2.3B | 1.0x | 5.0x | |
| $2.3B | 6.2x | 17.5x | |
| $2.3B | 0.9x | 6.8x | |
| $2.1B | 0.9x | 6.7x | |
| $2.1B | 2.7x | 18.8x | |
| $2.0B | 1.7x | 13.3x | |
| $2.0B | 1.2x | 9.6x | |
| $2.0B | 3.5x | 17.7x | |
| $1.9B | 1.0x | 7.7x | |
| $1.7B | 2.3x | 11.8x | |
| $1.6B | 0.8x | 8.0x | |
| $1.6B | n/a | n/a | |
| $1.6B | 1.5x | -237.3x | |
| $1.6B | n/a | n/a | |
| $1.4B | n/a | n/a | |
| $1.4B | n/a | n/a | |
| $1.3B | 1.7x | 7.1x | |
| $1.3B | 0.6x | 5.6x | |
| $1.1B | 8.5x | 31.8x | |
| $986M | 1.4x | 9.4x | |
| $960M | 3.8x | 68.5x | |
| $879M | 0.8x | 7.6x | |
| $794M | 1.1x | 5.5x | |
| $786M | 1.9x | 8.1x | |
| $730M | n/a | n/a | |
| $694M | 1.6x | 7.6x | |
| $671M | n/a | n/a | |
| $656M | n/a | n/a | |
| $594M | 0.4x | n/a | |
| $577M | 2.0x | -30.6x | |
| $575M | 1.4x | 9.0x | |
| $574M | n/a | n/a | |
| $554M | 0.8x | 6.4x | |
| $491M | 0.2x | 1.4x | |
| $475M | 2.3x | -39.5x | |
| $391M | 1.4x | 9.7x | |
| $353M | 1.5x | n/a | |
| $344M | 0.8x | 9.8x | |
| $328M | 1.1x | 11.8x | |
| $324M | n/a | n/a | |
| $300M | n/a | n/a | |
| $253M | 1.0x | 9.7x | |
| $239M | n/a | n/a | |
| $229M | 1.6x | 7.1x | |
| $211M | 4.1x | 15.5x | |
| $208M | 0.4x | 12.0x | |
| $206M | 0.5x | 8.7x | |
| $196M | 1.0x | 4.7x | |
| $194M | 2.4x | 13.5x | |
| $191M | n/a | n/a | |
| $175M | 0.9x | 8.8x | |
| $175M | 0.9x | 5.9x | |
| $139M | n/a | n/a | |
| $138M | 2.3x | 8.6x | |
| $132M | 0.5x | 6.1x | |
| $110M | 1.0x | -26.9x | |
| $87.9M | n/a | n/a | |
| $84.4M | n/a | n/a | |
| $77.4M | 0.3x | 4.1x | |
| $63.7M | 1.5x | n/a | |
| $59.9M | n/a | n/a | |
| $46.5M | 1.8x | 7.6x | |
| $42.5M | n/a | n/a | |
| $39.4M | n/a | n/a | |
| $33.7M | n/a | n/a | |
| $26.7M | n/a | n/a | |
| $20.2M | 1.1x | -12.1x | |
| $16.4M | n/a | n/a | |
| $16.4M | n/a | n/a | |
| $13.5M | n/a | n/a | |
| $7.6M | n/a | n/a | |
| $6.2M | n/a | n/a | |
| $1.8M | n/a | n/a | |
| -$27.4M | -0.1x | -3.8x | |
| -$61.1M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty